openPR Logo
Press release

Coronary Stents Market Size, Share, Industry Growth Report 2024-2031 | Cardinal Health, Biosensors International, Terumo Corporation, Transluminal GmbH, Boston Scientific

07-21-2025 08:47 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Coronary Stents Market - DataM Intelligence

Coronary Stents Market - DataM Intelligence

Coronary Stents Market is estimated to grow at a CAGR of 3.2% during the forecast period 2024-2031

The Coronary Stents Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/coronary-stents-market?sg

Coronary Stents Market Overview:

A coronary stent is a small, mesh-like tube inserted into the coronary arteries to help maintain blood flow to the heart by keeping the arteries open. It is commonly used during a procedure known as percutaneous coronary intervention (PCI), which treats coronary artery disease. Stents are typically deployed following balloon angioplasty, where the artery is first widened. Notably, over 90% of PCI procedures involve the placement of coronary stents to prevent artery re-narrowing and reduce the risk of future cardiac events.

Coronary Stents Market: Shifting Industry Trends

Rapid Technological Advancements Fueling Growth in the Coronary Stent Market

The coronary stent market is experiencing significant momentum, largely driven by ongoing technological innovations aimed at improving the safety, efficacy, and precision of treatment for complex coronary artery disease. Over the years, coronary stents have played a critical role in both coronary and peripheral procedures, particularly in managing arterial perforations and maintaining vessel patency post-angioplasty.

The field of percutaneous coronary intervention (PCI) continues to evolve, with healthcare manufacturers focusing on the development of advanced stent technologies that offer superior deliverability and biocompatibility. For example, in February 2018, Medtronic received FDA approval for its Resolute Onyx 2 mm stent-one of the smallest drug-eluting stents available-designed specifically for treating extremely narrow vessels, reflecting the market's push toward specialized, high-performance devices.

In addition, the rising preference for minimally invasive surgical procedures is a key growth driver. These procedures help reduce postoperative trauma, complications, and recovery time, while also shortening hospital stays. This demand is fostering the adoption of next-generation coronary stents that support quicker and safer interventions.

Advancements in drug-eluting stent (DES) technology have particularly contributed to market growth. Innovations include the enhancement of stent delivery systems and the development of more biocompatible drug coatings and polymer platforms, which help reduce inflammation and restenosis rates. Collectively, these factors are expected to create significant growth opportunities in the global coronary stent market in the coming years.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/coronary-stents-market?sg

Strategic Key Players Driving the Coronary Stents Market Forward: Abbott Laboratories, B. Braun Medical Inc, Biosensors International Group Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Cook Medical Technologies, Medtronic PLC, Terumo Corporation, Transluminal GmbH and Cardinal Health.

Research Methodology:

The global Coronary Stents Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Coronary Stents Market:

By Product Type (Bare-metal Stents, Drug-Eluting Stents, Bioabsorbable Stents)

By Material (Metallic, Polymeric, Natural Biomaterial, Others)

By End-User (Hospitals, Cardiac Specialty Clinics, Ambulatory Surgical Centers)

By Region (North America, South America, Europe, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Regional Analysis for Coronary Stents Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Coronary Stents Market Research Industry:

➠ Who leads the Coronary Stents industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Coronary Stents market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Coronary Stents market growth?

➠ What are the dominant sales and distribution strategies in the Coronary Stents industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coronary Stents Market Size, Share, Industry Growth Report 2024-2031 | Cardinal Health, Biosensors International, Terumo Corporation, Transluminal GmbH, Boston Scientific here

News-ID: 4111302 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Future of United States Breast Augmentation Market to hit US$ 3,440.6 million by 2031 | Cosmetic Surgery Innovations | Johnson & Johnson, AbbVie, Sientra, Inc., GC Aesthetics, POLYTECH Health & Aesthetics GmbH
Future of United States Breast Augmentation Market to hit US$ 3,440.6 million by …
The Global Breast Augmentation Market reached US$ 1,289.6 million in 2023 and is expected to reach US$ 3,440.6 million by 2031, growing at a CAGR of 13.0% during the forecast period 2024-2031. The Breast Augmentation Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their
Pulse Oximetry in the United States to hit US$ 6.68 Billion By 2033: Market Report & Outlook | Top Most Keyplayers - Masimo, Medtronic plc, Koninklijke Philips N.V.
Pulse Oximetry in the United States to hit US$ 6.68 Billion By 2033: Market Repo …
Pulse Oximeter Market reached US$ 3.34 Billion in 2024 and is expected to reach US$ 6.68 Billion by 2033, growing at a CAGR of 7.9 % during the forecast period 2025-2033. The Pulse Oximeter Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative
Future of United States Neuromodulation Devices Market to hit US$ 190.14 Billion by 2033 | Innovations in Neurotech | Medtronic, Abbott, Boston Scientific Corporation, Integer Holdings Corporation
Future of United States Neuromodulation Devices Market to hit US$ 190.14 Billion …
The global neuromodulation devices market was valued at US$ 98.05 Billion, and the market reached US$ 104.26 Billion in 2024 and is expected to reach US$ 190.14 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033. The Neuromodulation Devices Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in
United States Biomaterials Market Dynamics to hit US$486.83 Million by 2033 | Challenges & Growth Drivers | Major Companies likes - BASF SE, Evonik Industries AG, Royal DSM N.V..
United States Biomaterials Market Dynamics to hit US$486.83 Million by 2033 | Ch …
Biomaterials Market reached US$177.30 Million in 2024 and is expected to reach US$486.83 Million by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033, according to DataM Intelligence report. The Biomaterials Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients